Allergan PLC. (AGN) Holdings Raised by Capital World Investors

Capital World Investors grew its holdings in Allergan PLC. (NYSE:AGN) by 19.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 76,500 shares of the company’s stock after acquiring an additional 12,500 shares during the quarter. Capital World Investors’ holdings in Allergan PLC. were worth $18,596,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the business. Hudock Capital Group LLC increased its holdings in shares of Allergan PLC. by 0.4% in the second quarter. Hudock Capital Group LLC now owns 571 shares of the company’s stock worth $138,000 after acquiring an additional 2 shares in the last quarter. GWM Advisors LLC increased its holdings in shares of Allergan PLC. by 0.4% in the first quarter. GWM Advisors LLC now owns 1,260 shares of the company’s stock worth $300,000 after acquiring an additional 5 shares in the last quarter. Burns J W & Co. Inc. NY increased its holdings in shares of Allergan PLC. by 0.7% in the second quarter. Burns J W & Co. Inc. NY now owns 906 shares of the company’s stock worth $220,000 after acquiring an additional 6 shares in the last quarter. Pacific Center for Financial Services increased its holdings in shares of Allergan PLC. by 1.3% in the second quarter. Pacific Center for Financial Services now owns 541 shares of the company’s stock worth $132,000 after acquiring an additional 7 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC increased its holdings in shares of Allergan PLC. by 0.5% in the second quarter. Gilder Gagnon Howe & Co. LLC now owns 1,666 shares of the company’s stock worth $405,000 after acquiring an additional 9 shares in the last quarter. Institutional investors own 82.04% of the company’s stock.

Several equities research analysts have issued reports on the company. UBS AG restated an “outperform” rating and issued a $275.00 price target on shares of Allergan PLC. in a report on Wednesday, August 9th. BidaskClub downgraded Allergan PLC. from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Cowen and Company restated a “buy” rating on shares of Allergan PLC. in a report on Thursday. Wells Fargo & Company restated an “outperform” rating and issued a $280.00 price target (up from $270.00) on shares of Allergan PLC. in a report on Wednesday, August 9th. Finally, Barclays PLC restated an “equal weight” rating on shares of Allergan PLC. in a report on Monday, October 2nd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $271.64.

Allergan PLC. (NYSE:AGN) opened at 206.61 on Thursday. The firm has a market capitalization of $69.07 billion, a PE ratio of 6.29 and a beta of 1.15. Allergan PLC. has a 12 month low of $184.50 and a 12 month high of $256.80. The company’s 50-day moving average price is $216.96 and its 200 day moving average price is $232.50.

Allergan PLC. (NYSE:AGN) last announced its earnings results on Thursday, August 3rd. The company reported $4.02 earnings per share for the quarter, topping analysts’ consensus estimates of $3.95 by $0.07. Allergan PLC. had a return on equity of 7.37% and a net margin of 79.17%. The firm had revenue of $4.01 billion for the quarter, compared to the consensus estimate of $3.95 billion. During the same quarter in the previous year, the business earned $3.35 EPS. The company’s revenue was up 8.8% compared to the same quarter last year. On average, equities research analysts predict that Allergan PLC. will post $16.21 earnings per share for the current year.

Allergan PLC. declared that its board has approved a stock repurchase plan on Monday, September 25th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 2.8% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s management believes its shares are undervalued.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 15th. Stockholders of record on Friday, August 18th were paid a $0.70 dividend. The ex-dividend date was Wednesday, August 16th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.36%. Allergan PLC.’s payout ratio is presently 9.95%.

COPYRIGHT VIOLATION NOTICE: “Allergan PLC. (AGN) Holdings Raised by Capital World Investors” was first posted by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.com-unik.info/2017/10/12/allergan-plc-agn-holdings-raised-by-capital-world-investors.html.

Allergan PLC. Profile

Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.

Want to see what other hedge funds are holding AGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allergan PLC. (NYSE:AGN).

Institutional Ownership by Quarter for Allergan PLC. (NYSE:AGN)

What are top analysts saying about Allergan PLC.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Allergan PLC. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit